Clinical Trials Browser

Phase 2 × Melanoma × daromun × Clear all

NCT06284590 2024-10-26

INTACT/MeRCI

Phase 2 Recruiting

Melanoma

NCT02076633 2015-05-27

Intratumoral Administration of L19IL2/L19TNF

Phase 2 Completed

Melanoma